Bayer CropScience announced that EverGolTM seed treatment fungicide today was registered by the Environmental Protection Agency (EPA) and will be available in the U.S. market in cotton, canola and wheat for the 2013 crop season. The newest member of Bayer CropScience's seed treatment portfolio, EverGol offers long-lasting protection against Rhizoctonia and other problematic diseases, helping to ensure better crop establishment and improved growth.

"EverGol is the newest fungicide in the seed treatment industry to propel the future of farming for growers in the United States," stated Phil Gibson, seed treatment product manager, Bayer CropScience. "Studies have shown that EverGol treated seeds are quicker to emerge, grow faster and result in better crop establishment."

In addition, EverGol formulations and their active ingredient Penflufen will provide growers with broader performance disease protection, including control of Rhizoctonia fungi and general seed decay. EverGol also promotes better stands under disease pressure and improves crop vigor which can lead to more efficient use of water and nutrients.

"With commodity prices for crops continuing to be above historical averages, the benefits of EverGol's increased plant protection makes it a smart fungicidal seed treatment decision in which growers can be confident," said Gibson.

The EverGol portfolio of products in the United States will include:

• EverGolTM Prime for cotton
• Prosper(R) EverGolTM for canola
• EverGolTM Energy for wheat

"Bayer is committed to providing growers with new agricultural solutions and improved seed treatment technology," stated Bill Striegel, product development manager, Bayer CropScience. "The launch of EverGol will provide growers with a new tool to help protect their crop and yield potential."

To learn more about Bayer CropScience, visit http://www.bayercropscience.us or contact your local sales representative for product information.

About Bayer CropScience
Bayer is a global enterprise with core competencies in the fields of health care, nutrition and high-tech materials. Bayer CropScience, a subgroup of Bayer AG with annual sales of EUR 6.830 billion (2010), is one of the world's leading innovative crop science companies in the areas of crop protection, non-agricultural pest control, seeds and traits. The company offers an outstanding range of products and extensive service backup for modern, sustainable agriculture and for non-agricultural applications. Bayer CropScience has a global workforce of 20,700 and is represented in more than 120 countries. This and further news is available at: http://www.press.bayercropscience.com.

Contact:
Bayer CropScience Media Hotline, 1-877-879-6162, or

Beth Roden
External Communications Lead
Bayer CropScience
Tel: (919) 549-2030
Email: beth.roden(at)bayer(dot)com

Jennifer Furey
Porter Novelli
Tel: (312) 552-6310
Email: jennifer.furey(at)porternovelli(dot)com

Find more information at http://www.bayercropscience.us.

USA-BCS-2012-0217

Forward-Looking Statements
This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer's public reports which are available on the Bayer website at http://www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.

©2012 Bayer CropScience LP, 2 T.W. Alexander Drive, Research Triangle Park, NC 27709. Always read and follow label instructions. Bayer, the Bayer Cross, EverGol, and Prosper are trademarks of Bayer. Not all products are registered in all states. For additional product information call toll-free 1-866-99-BAYER (1-866-992-2937) or visit our Website at http://www.bayercropscience.com.

Read the full story at http://www.prweb.com/releases/2012/5/prweb9506463.htm

PRWeb.com